Cargando…

COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies

Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and transmissible coronavirus. Most cases of COVID‐19 have mild to moderate symptoms, including cough, fever, myalgias, and headache. On the other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polatoğlu, Ilker, Oncu‐Oner, Tulay, Dalman, Irem, Ozdogan, Senanur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082934/ https://www.ncbi.nlm.nih.gov/pubmed/37041762 http://dx.doi.org/10.1002/mco2.228

Ejemplares similares

The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician’s attitudes toward hypertension treatment
por: Sarı, Cenk, et al.
Publicado: (2020)

Recent Developments in Enzyme, DNA and Immuno-Based Biosensors
por: Asal, Melis, et al.
Publicado: (2018)

SARS-CoV-2 rapid diagnostic tests for emerging variants
por: Bekliz, Meriem, et al.
Publicado: (2021)

Exploring genetic diversity and population structure of a large grapevine (Vitis vinifera L.) germplasm collection in Türkiye
por: Kaya, Hilal Betul, et al.
Publicado: (2023)

SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States
por: Thomas, Emmanuel, et al.
Publicado: (2021)

Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms — China, December 2022–February 2023
por: Fu, Di, et al.
Publicado: (2023)

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
por: Hawman, David W, et al.
Publicado: (2022)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 — Worldwide, July–October 2023
por: Lambrou, Anastasia S., et al.
Publicado: (2023)

Prevalence of Low-Frequency, Antiviral Resistance Variants in SARS-CoV-2 Isolates in Ontario, Canada, 2020-2023
por: Sjaarda, Calvin P., et al.
Publicado: (2023)

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
por: Mudrick, Haley E., et al.
Publicado: (2022)

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
por: Hawman, David W., et al.
Publicado: (2021)

Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
por: Zabidi, Nur Zawanah, et al.
Publicado: (2023)

The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant — Guangdong Province, China, December 2022 to January 2023
por: Cai, Chunsheng, et al.
Publicado: (2023)

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023
por: Ma, Kevin C., et al.
Publicado: (2023)

Copper acetate aerosols: A possible tool complementary to vaccination in fight against SARS-CoV-2 and variants replication
por: Deloncle, Roger, et al.
Publicado: (2022)

Diagnostic Salivary Tests for SARS-CoV-2
por: Azzi, L., et al.
Publicado: (2020)

The Interpretation of SARS-CoV-2 Diagnostic Tests
por: Stites, Edward C., et al.
Publicado: (2020)

Diagnostic Testing for SARS-CoV-2 Infection
por: Thomas, Emmanuel, et al.
Publicado: (2021)

Rapid Diagnostic Testing for SARS-CoV-2
por: Drain, Paul K.
Publicado: (2022)

Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern
por: Raïch-Regué, Dàlia, et al.
Publicado: (2022)

SARS-CoV-2 Variants BQ.1 and XBB.1.5 in Wastewater of Aircraft Flying from China to Denmark, 2023
por: Qvesel, Amanda Gammelby, et al.
Publicado: (2023)

COVID-19 vaccines in 2023
por: Sharma, Ketaki, et al.
Publicado: (2023)

Detection of SARS-CoV-2 variants by multiple diagnostic assays
por: Feumba, G. Stephanie, et al.
Publicado: (2022)

Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023
por: Scobie, Heather M., et al.
Publicado: (2023)

A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual
por: Caccuri, Francesca, et al.
Publicado: (2020)

SARS-CoV-2 variants reveal features critical for replication in primary human cells
por: Pohl, Marie O., et al.
Publicado: (2021)

Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin
por: Al-Beltagi, Sarah, et al.
Publicado: (2021)

Virus replication and competition in a cell culture: Application to the SARS-CoV-2 variants
por: Ait Mahiout, L., et al.
Publicado: (2022)

SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication
por: Alexandersen, Soren, et al.
Publicado: (2020)

The pharmacist’s role in SARS-CoV-2 diagnostic testing
por: Goode, Jean-Venable R., et al.
Publicado: (2020)

Development of Diagnostic Tests for Detection of SARS-CoV-2
por: Nguyen, Ngan N. T., et al.
Publicado: (2020)

Update on rapid diagnostic testing for SARS-CoV-2
por: Dugerdil, Adeline, et al.
Publicado: (2022)

First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
por: Rasmussen, Morten, et al.
Publicado: (2023)

Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eckha8sbpq7ak1cetlp21uclc8